Biojournals.com
advertising

         

Latest Publications on atteritano
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women.
This study aimed at evaluating the effects of genistein (54 mg/die) on ...
Atteritano M, Mazzaferro S, Frisina A, Cannata ML, Bitto A, D'Anna R, Squadrito F, Macri I, Frisina N, Buemi M,
http://dx.doi.org/10.1007/s00198-009-0883-4
Osteoporos Int. 2009 Feb 24.

Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study.
OBJECTIVE: To evaluate in a 24-month, prospective, randomized, ...
D'Anna R, Cannata ML, Marini H, Atteritano M, Cancellieri F, Corrado F, Triolo O, Rizzo P, Russo S, Gaudio A, Frisina N, Bitto A, Polito F, Minutoli L, Altavilla D, Adamo EB, Squadrito F,
http://dx.doi.org/10.1097/gme.0b013e318186d7e2
Menopause. 2009 Mar-Apr;16(2):301-6.

Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study.
CONTEXT: Genistein aglycone improves bone metabolism in women. However, ...
Marini H, Bitto A, Altavilla D, Burnett BP, Polito F, Di Stefano V, Minutoli L, Atteritano M, Levy RM, D'Anna R, Frisina N, Mazzaferro S, Cancellieri F, Cannata ML, Corrado F, Frisina A, Adamo V, Lubrano C, Sansotta C, Marini R, Adamo EB, Squadrito F,
http://dx.doi.org/10.1210/jc.2008-1087
J Clin Endocrinol Metab. 2008 Dec;93(12):4787-96. Epub 2008 Sep 16.

Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study.
To evaluate in a twelve-month, randomized placebo-controlled study whether ...
Atteritano M, Pernice F, Mazzaferro S, Mantuano S, Frisina A, D'Anna R, Cannata ML, Bitto A, Squadrito F, Frisina N, Buemi M,
http://dx.doi.org/10.1016/j.ejphar.2008.04.049
Eur J Pharmacol. 2008 Jul 28;589(1-3):22-6. Epub 2008 May 3.

OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration.
INTRODUCTION: RANKL and its decoy receptor osteoprotegerin (OPG) ...
Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, Gaudio A, Mazzaferro S, Frisina A, Frisina N, Lubrano C, Bonaiuto M, D'Anna R, Cannata ML, Corrado F, Cancellieri F, Faraci M, Marini R, Adamo EB, Wilson S, Squadrito F,
http://dx.doi.org/10.1359/jbmr.080201
J Bone Miner Res. 2008 May;23(5):715-20.

    Resources from NCBI applied. Nothing on this site should be taken as medical advice.


Latest searches:fallis | XLXX | Neurotransmission | Neurochemistry | XLXX |

04/Jul/2009:00:49:59